Subscribe
shutterstock_1207956820_jhvephoto
jhvephoto / Shutterstock.com
30 July 2019Americas

Federal Circuit dismisses Amgen’s Neulasta appeal

California-based  Amgen is barred from succeeding on its patent infringement claim against  Coherus Biosciences, according to the US Court of Appeals for the Federal Circuit.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Amgen settles with Coherus over arthritis treatment
28 November 2019   Amgen and Coherus Biosciences have settled a patent infringement dispute, after Coherus claimed that Amgen was infringing three of its patents.
Americas
Coherus attempts to dismiss Amgen’s Neulasta suit
12 June 2017   Coherus BioSciences has asked a court to dismiss patent infringement allegations brought against it by Amgen.
Americas
Amgen sets sights on Coherus over biologic drug
12 May 2017   Amgen has set its sights on Coherus Biosciences, a biosimilar maker, for allegedly infringing a patent concerning a process for purifying proteins.


Editor's picks

UKIPO rejects Boehringer’s SPC for horse inhaler
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025

Editor's picks

Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

More on this story

Big Pharma
Amgen settles with Coherus over arthritis treatment
28 November 2019   Amgen and Coherus Biosciences have settled a patent infringement dispute, after Coherus claimed that Amgen was infringing three of its patents.
Americas
Coherus attempts to dismiss Amgen’s Neulasta suit
12 June 2017   Coherus BioSciences has asked a court to dismiss patent infringement allegations brought against it by Amgen.
Americas
Amgen sets sights on Coherus over biologic drug
12 May 2017   Amgen has set its sights on Coherus Biosciences, a biosimilar maker, for allegedly infringing a patent concerning a process for purifying proteins.

More on this story

Big Pharma
Amgen settles with Coherus over arthritis treatment
28 November 2019   Amgen and Coherus Biosciences have settled a patent infringement dispute, after Coherus claimed that Amgen was infringing three of its patents.
Americas
Coherus attempts to dismiss Amgen’s Neulasta suit
12 June 2017   Coherus BioSciences has asked a court to dismiss patent infringement allegations brought against it by Amgen.
Americas
Amgen sets sights on Coherus over biologic drug
12 May 2017   Amgen has set its sights on Coherus Biosciences, a biosimilar maker, for allegedly infringing a patent concerning a process for purifying proteins.

More features

Chicago firm Much Shelist adds partner with ‘entrepreneurial mindset’
Powell Gilbert launches Düsseldorf office with leading patent litigator
Startups toolkit: Why investors want more than patents
J&J fends off generic schizophrenia drug bids
Kilpatrick adds ‘seasoned litigator’ as trademark partner
WATCH: An update on EPO Board of Appeal strategy for 2025 and beyond
Startup challenges rival over brain monitoring tech at ITC
UKIPO rejects Boehringer’s SPC for horse inhaler